ALSO READDr Reddy's Lab outlicenses DFD-06 to Encore Dermatology Dr Reddy's gets favourable verdict on patent litigation of drug Suboxone Dr Reddy's says German regulator makes six observations on unit Dr Reddy's fourth-quarter profit misses estimates as U.S. sales slump Dr Reddy's fourth quarter profit misses estimates, stumbles on U.S. regulatory hurdles
Import of Defence technology may kill innovation in Indian companies and it should be allowed only when there is no homegrown technology available, according to Dr G Satheesh Reddy, Scientific Advisor to Raksha Mantri.
Innovation should come as building competitiveness and not to become a hindrance, he said.
While acknowledging CII's efforts in deliberating the role of Defence R&D in Make in India, Dr Reddy further suggested that Make in India should not stop at Build to Print, and instead, should involve indigenous design, development and manufacturing. AAKASH missile and MRSAM programme came as his references where Indian industry has substantially contributed through build to specifications systems.
Dr S Guruprasad, Scientist & Director General (PC&SI), DRDO also addressed during the occasion and urged the Indian Industry to make the best possible use of Technology Development Fund (TDF), an initiative of MoD, executed through DRDO, to develop indigenous capability. For making India self-reliant in Defence, Dr Guruprasad stressed on the need for industry to continue with R&D activities and also to collaborate with DRDO for technologies. He further urged Indian industry to exercise caution while partnering with foreign firms, especially in cases where there is a clause on R&D.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)